Physician profile
Nathan Bining
NPI 1538102165
$7,019.22
in general payments reported to CMS, 2019-2025
41 companies · $1,604 in 2025
The $1,604 reported for 2025 was more than what 91% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $816 · 2020: $744 · 2021: $1,066 · 2022: $1,059 · 2023: $638 · 2024: $1,092 · 2025: $1,604.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,334.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,334.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $1,217.61 | 2019-2025 | Arexvy, Shingrix, Trelegy Ellipta |
| Astrazeneca Pharmaceuticals Lp | $797.55 | 2020-2025 | Breztri, Farxiga, Airsupra |
| Abbvie INC. | $669.30 | 2021-2025 | Qulipta, Ubrelvy, Vraylar |
| Pfizer INC. | $583.83 | 2019-2024 | |
| Indivior INC. | $450.72 | 2021-2025 | Sublocade |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $386.34 | 2024-2025 | Caplyta |
| Lilly USA, LLC | $363.72 | 2019-2025 | Mounjaro, Zepbound |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $251.42 | 2019-2024 | Relistor |
| Biohaven Pharmaceutical Holding Company Ltd. | $208.18 | 2022 | |
| Exact Sciences Corporation | $180.38 | 2023-2025 | Cologuard Collection Kit |
| Merck Sharp & Dohme LLC | $152.05 | 2019-2023 | Verquvo, Belsomra |
| Novartis Pharmaceuticals Corporation | $146.76 | 2019-2022 | |
| Allergan, INC. | $119.23 | 2020 | |
| Collegium Pharmaceutical, INC. | $118.18 | 2022-2023 | Belbuca |
| Amarin Pharma, INC. | $116.23 | 2020-2021 |
Show all 41 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nathan Bining listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.